Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Toxicon ; 33(12): 1605-17, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8866618

RESUMO

Jararhagin, a haemorrhagic metalloproteinase from Bothrops jararaca venom, plays an important role in systemic as well as local haemorrhage. In this study, the effect of jararhagin on the fibrinolytic system was investigated. The fibrinolytic activity of various kinds of animal plasmas was measured by the fibrin plate method. No activity was detected in plasma alone. However, after mixing plasma with jararhagin, strong fibrinolytic activity was recorded in guinea-pig, horse, dog, rabbit and human plasmas. The mechanism of the increase of firbinolytic activity by jararhagin was studied further in guinea-pig plasma. Fibrin-zymographic studies indicated that jararhagin increased tissue-type plasminogen activator (tPA) activity by the dissociation of a complex of tPA with type 1 plasminogen activator inhibitor (PAI-1). alpha 2-Plasmin inhibitor (alpha 2-PI) activity in the plasma was measured using a synthetic chromogenic substrate method after incubation with jararhagin. The alpha 2-PI activity in the plasma decreased in both time-dependent and dose-dependent manners. These in vitro results suggest that, in some animal plasmas, jararhagin increases plasma fibrinolytic activity by causing dissociation of the tPA/PAI-1 complex and by the inactivation of alpha 2-PI. It is possible that this direct action of jararhagin on the enhancement of plasma fibrinolytic activity may contribute to the aetiology of systemic haemorrhage frequently observed in human victims of B. jararaca envenoming.


Assuntos
Venenos de Crotalídeos/toxicidade , Fibrinólise/efeitos dos fármacos , Hemorragia/induzido quimicamente , Metaloendopeptidases/toxicidade , Inibidores da Agregação Plaquetária/toxicidade , Inibidores de Serina Proteinase/toxicidade , Animais , Proteínas Sanguíneas/metabolismo , Venenos de Crotalídeos/administração & dosagem , Venenos de Crotalídeos/isolamento & purificação , Venenos de Crotalídeos/metabolismo , Cães , Eletroforese em Gel de Poliacrilamida , Cobaias , Cavalos , Humanos , Metaloendopeptidases/administração & dosagem , Metaloendopeptidases/isolamento & purificação , Metaloendopeptidases/metabolismo , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Inibidor 1 de Ativador de Plasminogênio/toxicidade , Inibidores da Agregação Plaquetária/administração & dosagem , Inibidores da Agregação Plaquetária/metabolismo , Coelhos , Inibidores de Serina Proteinase/metabolismo , Ativador de Plasminogênio Tecidual/efeitos dos fármacos , Ativador de Plasminogênio Tecidual/metabolismo , alfa 2-Antiplasmina/análise , alfa 2-Antiplasmina/metabolismo , Veneno de Bothrops jararaca
2.
Toxicon ; 33(5): 703-5, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7660375

RESUMO

The bites of six species of venomous elapid snakes in Central Province Papua New Guinea produce similar clinical syndromes. Optimal management of envenomed patients involves the use of monospecific antivenom. In this study, Venom Detection Kits (VDKs) (CSL Diagnostics, Melbourne) were used to try to make a specific diagnosis in envenomed patients at their admission. VDKs detected venom in admission bite site swabs from 39 to 46 patients (85%). Thirty-eight of these patients were shown to have been bitten by taipans. In all cases where venom was detected by the VDK, this correlated with subsequent laboratory enzyme immunoassay results. Selective use of VDKs in Central Province could allow more widespread use of monospecific antivenoms and produce considerable financial savings.


Assuntos
Kit de Reagentes para Diagnóstico , Mordeduras de Serpentes/diagnóstico , Venenos de Serpentes/análise , Antivenenos/economia , Humanos , Técnicas Imunoenzimáticas , Nova Guiné/epidemiologia , Mordeduras de Serpentes/epidemiologia , Mordeduras de Serpentes/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA